Our NGS analysis of 27 SMARCA4‐deficient thoracic tumors identified frequent mutations in TP53, CDKN2A, KRAS, STK11, NF1, and PTEN, with rare actionable oncogenic driver mutations.6, 17. The gene discussed is TP53; the disease is neoplasm of thorax.